Novanta (NASDAQ:NOVT) Issues FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 3.660-3.710 for the period, compared to the consensus EPS estimate of 3.690. The company issued revenue guidance of $1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q4 2026 guidance to 0.910-0.960 EPS.

Novanta Price Performance

NASDAQ NOVT opened at $123.94 on Tuesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.57 and a quick ratio of 3.79. The stock’s fifty day moving average price is $142.25 and its 200 day moving average price is $142.59. Novanta has a 1 year low of $98.27 and a 1 year high of $176.38. The company has a market cap of $4.69 billion, a price-to-earnings ratio of 86.50 and a beta of 1.71.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Monday, November 9th. The technology company reported $1.05 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. The company had revenue of $305.01 million during the quarter, compared to analysts’ expectations of $301.02 million. Novanta had a return on equity of 10.83% and a net margin of 6.00%. The firm’s revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.87 EPS. As a group, equities research analysts forecast that Novanta will post 3.70 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on NOVT. Robert W. Baird set a $194.00 price objective on Novanta in a research note on Friday, August 7th. Zacks Research lowered Novanta from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Wall Street Zen upgraded shares of Novanta from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research report on Tuesday, October 13th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $194.00.

About Novanta

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software.

The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

Novanta was formerly known as GSI Group and adopted the Novanta name in 2016.